Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer-Reference-Cited by-同舟云学术

Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer

Published:2007 Issue:2 Volume:29 Page:137-142
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Allen Aaron M.,Elshaikh Mohamed,Worden Francis P.,Bradford Carol R.,Teknos Theodoros N.,Chepeha Douglas B.,Tsien Christina,Dawson Laura A.,Urba Susan,Wolf Gregory T.,Normolle Daniel,Eisbruch Avraham

Publisher

Wiley

Subject

Otorhinolaryngology

Reference25 articles.

1. Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer

2. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

3. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

4. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

5. Maximizing Local Control and Organ Preservation in Stage IV Squamous Cell Head and Neck Cancer With Hyperfractionated Radiation and Concurrent Chemotherapy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological and functional outcomes of partial or total laryngopharyngectomy for hypopharyngeal cancer with thyroid or cricoid cartilage invasion;Acta Oto-Laryngologica;2023-05-02

2. Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy;Head & Neck;2020-10-05

3. Systematic review and meta‐analysis of the impact of dosimetry to dysphagia and aspiration related structures;Head & Neck;2019-01-24

4. Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status;Oncotarget;2017-01-17

5. Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?;Oral Oncology;2016-03